DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
+13.03%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$186M
AUM Growth
+$186M
(+15%)
Cap. Flow
+$26.3M
Cap. Flow
% of AUM
14.19%
Top 10 Holdings %
Top 10 Hldgs %
43.12%
Holding
84
New
10
Increased
19
Reduced
10
Closed
11
Top Buys
| 1 |
SAGE
Sage Therapeutics
SAGE
|
$4.74M |
| 2 |
VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
|
$4.26M |
| 3 |
argenx
ARGX
|
$3.5M |
| 4 |
ZGNX
Zogenix, Inc.
ZGNX
|
$3.27M |
| 5 |
LOXO
Loxo Oncology, Inc
LOXO
|
$2.85M |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$2.53M |
| 2 |
Insulet
PODD
|
$1.72M |
| 3 |
uniQure
QURE
|
$1.68M |
| 4 |
NDRM
NeuroDerm Ltd. Ordinary Shares
NDRM
|
$1.48M |
| 5 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$1.03M |
Sector Composition
| 1 | Healthcare | 82.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LOXO
1
DELISTED
Loxo Oncology, Inc
LOXO
| $24.9M | 13.42% | 296,000 +33,879 | +13% | +$2.85M |
|
|
BPMC
2
DELISTED
Blueprint Medicines
BPMC
| $7.59M | 4.09% | 100,691 +24,691 | +32% | +$1.86M |
|
3
AtriCure
ATRC
$1.84B
| $7.1M | 3.82% | 389,145 +5,000 | +1% | +$91.2K |
|
|
AERI
4
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $6.98M | 3.76% | 116,770 | – | – |
|
|
5
argenx
ARGX
$43.6B
| $6.02M | 3.24% | 95,396 +55,396 | +138% | +$3.5M |
|
|
ONC
6
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $6M | 3.23% | 61,349 -10,500 | -15% | -$1.03M |
|
7
BioCryst Pharmaceuticals
BCRX
$1.74B
| $5.86M | 3.16% | 1,193,228 | – | – |
|
|
ZGNX
8
DELISTED
Zogenix, Inc.
ZGNX
| $5.37M | 2.89% | 134,147 +81,647 | +156% | +$3.27M |
|
|
NXTM
9
DELISTED
NxStage Medical Inc.
NXTM
| $5.24M | 2.82% | 216,119 | – | – |
|
10
Ascendis Pharma
ASND
$11.8B
| $4.99M | 2.69% | 124,639 +52,413 | +73% | +$2.1M |
|
|
IMMU
11
DELISTED
Immunomedics Inc
IMMU
| $4.91M | 2.65% | 304,000 -156,451 | -34% | -$2.53M |
|
12
DexCom
DXCM
$29.5B
| $4.76M | 2.57% | 83,000 +25,500 | +44% | +$1.46M |
|
|
SAGE
13
DELISTED
Sage Therapeutics
SAGE
| $4.74M | 2.55% | +28,800 | New | +$4.74M |
|
|
VBIV
14
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $4.26M | 2.29% | +998,000 | New | +$4.26M |
|
15
Neurocrine Biosciences
NBIX
$13.8B
| $4.23M | 2.28% | 54,508 | – | – |
|
|
ALDR
16
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $3.96M | 2.13% | 346,013 | – | – |
|
17
Rigel Pharmaceuticals
RIGL
$697M
| $3.82M | 2.06% | 983,478 +540,000 | +122% | +$2.1M |
|
18
Galapagos
GLPG
$2.07B
| $3.71M | 2% | 39,609 +8,000 | +25% | +$750K |
|
|
CBAY
19
DELISTED
Cymabay Therapeutics
CBAY
| $3.32M | 1.79% | 361,164 -73,836 | -17% | -$679K |
|
20
MacroGenics
MGNX
$112M
| $2.93M | 1.58% | 154,200 | – | – |
|
|
VIRX
21
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $2.89M | 1.56% | 783,000 -48,332 | -6% | -$178K |
|
22
iShares Biotechnology ETF
IBB
$5.6B
| $2.79M | 1.5% | 26,100 +17,400 | +200% | +$1.86M |
|
|
ACHN
23
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $2.73M | 1.47% | 948,272 +230,000 | +32% | +$662K |
|
|
BEAT
24
DELISTED
BioTelemetry, Inc.
BEAT
| $2.63M | 1.42% | 88,100 +38,100 | +76% | +$1.14M |
|
25
Voyager Therapeutics
VYGR
$186M
| $2.61M | 1.4% | 157,000 +39,741 | +34% | +$660K |
|